Integer Holdings’s (NYSE:ITGR) Q1 Sales Beat EstimatesMedical technology company Integer Holdings (
NYSE:ITGR) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 7.3% year on year to $437.4 million. The company expects the full year’s revenue to be around $1.86 billion, close to analysts’ estimates. Its non-GAAP profit of $1.31 per share was 5.5% above analysts’ consensus estimates.
Integer Holdings (ITGR) Q1 Earnings: What To ExpectMedical technology company Integer Holdings (
NYSE:ITGR)
will be reporting earnings tomorrow before market hours. Here’s what you need to know.
Spotting Winners: STAAR Surgical (NASDAQ:STAA) And Medical Devices & Supplies - Specialty Stocks In Q4Looking back on medical devices & supplies - specialty stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including STAAR Surgical (
NASDAQ:STAA) and its peers.
3 Russell 2000 Stocks Walking a Fine LineThe Russell 2000 is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on.
However, these companies often come with higher volatility and risk, as their smaller size makes them more vulnerable to economic downturns.
Integer Holdings (ITGR): Buy, Sell, or Hold Post Q4 Earnings?Integer Holdings trades at $113.57 per share and has stayed right on track with the overall market, losing 11.4% over the last six months while the S&P 500 is down 7.7%. This may have investors wondering how to approach the situation.
Medical Devices & Supplies - Specialty Stocks Q4 Teardown: Integer Holdings (NYSE:ITGR) Vs The RestLet’s dig into the relative performance of Integer Holdings (
NYSE:ITGR) and its peers as we unravel the now-completed Q4 medical devices & supplies - specialty earnings season.
Medical Devices & Supplies - Specialty Stocks Q3 Recap: Benchmarking STAAR Surgical (NASDAQ:STAA)As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the medical devices & supplies - specialty industry, including STAAR Surgical (
NASDAQ:STAA) and its peers.
Q4 Earnings Roundup: Bausch + Lomb (NYSE:BLCO) And The Rest Of The Medical Devices & Supplies - Specialty SegmentLooking back on medical devices & supplies - specialty stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Bausch + Lomb (
NYSE:BLCO) and its peers.
Q4 Earnings Highs And Lows: Haemonetics (NYSE:HAE) Vs The Rest Of The Medical Devices & Supplies - Specialty StocksQuarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Haemonetics (
NYSE:HAE) and the best and worst performers in the medical devices & supplies - specialty industry.
A Look Back at Medical Devices & Supplies - Specialty Stocks’ Q3 Earnings: STAAR Surgical (NASDAQ:STAA) Vs The Rest Of The PackQuarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at STAAR Surgical (
NASDAQ:STAA) and the best and worst performers in the medical devices & supplies - specialty industry.
Integer Holdings (NYSE:ITGR) Posts Better-Than-Expected Sales In Q4, Full-Year Outlook Slightly Exceeds ExpectationsMedical technology company Integer Holdings (
NYSE:ITGR) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 11.1% year on year to $449.5 million. The company’s full-year revenue guidance of $1.86 billion at the midpoint came in 1.1% above analysts’ estimates. Its non-GAAP profit of $1.43 per share was 2% below analysts’ consensus estimates.
Earnings To Watch: Integer Holdings (ITGR) Reports Q4 Results TomorrowMedical technology company Integer Holdings (
NYSE:ITGR)
will be announcing earnings results tomorrow before market hours. Here’s what you need to know.